Pharma oncology, also known as pharmaceutical oncology, is the branch of pharmaceutical science that focuses on the development, production, and distribution of drugs used in the treatment of cancer. It involves researching and developing new drugs and therapies that can effectively target cancer cells while minimizing damage to healthy cells.

Pharmaceutical oncology also encompasses clinical trials and regulatory processes that ensure the safety and efficacy of cancer drugs before they are approved for use by the general public. Additionally, it involves collaborating with healthcare professionals to develop treatment plans that are tailored to individual patients.

The aim of pharma oncology is to improve the survival rates and quality of life for cancer patients by providing them safe and effective treatment options. Advances in pharma oncology have led to significant improvements in cancer care and have contributed to the development of targeted therapies and immunotherapies that are transforming the field of oncology.

    Related Conference of Pharma-Oncology

    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 24-25, 2024

    7th International Conference on Anti-Cancer Drugs

    Vancouver, Canada

    Pharma-Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in